Ignite Creation Date:
2025-12-24 @ 4:59 PM
Ignite Modification Date:
2026-01-04 @ 4:08 PM
Study NCT ID:
NCT01014650
Status:
COMPLETED
Last Update Posted:
2016-02-22
First Post:
2009-11-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single Ascending Dose Safety, Tolerability and Pharmacokinetics Study of GLYX-13 in Normal Volunteers
Sponsor:
Naurex, Inc, an affiliate of Allergan plc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GLYX13-C-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None